Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rutuja Suryawanshi
Institutions:
National Institute of Pharmaceutical Education and Research,
National Institute of Pharmaceutical Education and Research
Observed institutions:
National Institute of Pharmaceutical Education and Research,
National Institute of Pharmaceutical Education and Research
ORCID:
0009-0003-2015-8649
Observed ORCID:
0009-0003-2015-8649
OpenAlex ID:
A5133664191
Forced degradation study and impurity profiling of erlotinib hydrochloride using RP-HPLC and orbitrap LC-HRMS analysis and their in silico toxicity assessment
2026
·
Anumol Joseph
, Sideequl Akbar
, et al.
·
Journal of the Indian Chemical Society
·
1
Forced degradation studies of palbociclib using validated RP-HPLC method and elucidation of degradation pathways and qualifying impurities using LC-HRMS analysis: A preformulation protocol
2026
·
Rutuja Suryawanshi
, Anumol Joseph
, et al.
·
Journal of the Indian Chemical Society
An In silico model-based feasibility assessment of erlotinib long-acting injectable formulation for the management of metastatic non-small cell lung cancer
2026
·
Anumol Joseph
, Sideequl Akbar
, et al.
·
Xenobiotica
In silico designing of palbociclib loaded PLGA long-acting intramuscular injection for palliative therapy of HR+/HER2− metastatic breast cancer
2026
·
Rutuja Suryawanshi
, Anumol Joseph
, et al.
·
Journal of Pharmacy and Pharmacology
Show more works
View as search
Works count:
4
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type